Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 182, 2018 01 09.
Article in English | MEDLINE | ID: mdl-29317705

ABSTRACT

Streptococcus pneumoniae (S.pn.) is the most common bacterial pathogen causing community acquired pneumonia. The pore-forming toxin pneumolysin (PLY) is the major virulence factor of S.pn. and supposed to affect alveolar epithelial cells thereby activating the immune system by liberation of danger-associated molecular patterns (DAMP). To test this hypothesis, we established a novel live-cell imaging based assay to analyse mitochondrial function and associated release of mitochondrial DNA (mtDNA) as DAMP in real-time. We first revealed that bacterially released PLY caused significant changes of the cellular ATP homeostasis and led to morphologic alterations of mitochondria in human alveolar epithelial cells in vitro and, by use of spectral live-tissue imaging, in human alveoli. This was accompanied by strong mitochondrial calcium influx and loss of mitochondrial membrane potential resulting in opening of the mitochondrial permeability transition pore and mtDNA release without activation of intrinsic apoptosis. Moreover, our data indicate cellular mtDNA liberation via microvesicles, which may contribute to S.pn. related pro-inflammatory immune activation in the human alveolar compartment.


Subject(s)
Alveolar Epithelial Cells/drug effects , DNA, Mitochondrial/metabolism , Mitochondria/drug effects , Streptolysins/toxicity , Adenosine Triphosphate/metabolism , Alveolar Epithelial Cells/metabolism , Bacterial Proteins/toxicity , Calcium/metabolism , Cell Line, Tumor , Cells, Cultured , Humans , Membrane Potential, Mitochondrial , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Mitochondrial Permeability Transition Pore
2.
Eur Respir J ; 50(1)2017 07.
Article in English | MEDLINE | ID: mdl-28705941

ABSTRACT

The severity and lethality of influenza A virus (IAV) infections is frequently aggravated by secondary bacterial pneumonia. However, the mechanisms in human lung tissue that provoke this increase in fatality are unknown and therapeutic immune modulatory options are lacking.We established a human lung ex vivo co-infection model to investigate innate immune related mechanisms contributing to the susceptibility of secondary pneumococcal pneumonia.We revealed that type I and III interferon (IFN) inhibits Streptococcus pneumoniae-induced interleukin (IL)-1ß release. The lack of IL-1ß resulted in the repression of bacterially induced granulocyte-macrophage colony-stimulating factor (GM-CSF) liberation. Specific inhibition of IFN receptor I and III-associated tyrosine kinase 2 (Tyk2) completely restored the S. pneumoniae-induced IL-1ß-GM-CSF axis, leading to a reduction of bacterial growth. A preceding IAV infection of the human alveolus leads to a type I and III IFN-dependent blockade of the early cytokines IL-1ß and GM-CSF, which are key for orchestrating an adequate innate immune response against bacteria. Their virally induced suppression may result in impaired bacterial clearance and alveolar repair.Pharmacological inhibition of Tyk2 might be a new treatment option to sustain beneficial endogenous GM-CSF levels in IAV-associated secondary bacterial pneumonia.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Influenza, Human/drug therapy , Interferons/pharmacology , Pneumonia, Bacterial/drug therapy , Staphylococcal Infections/drug therapy , TYK2 Kinase/antagonists & inhibitors , Humans , Immunity, Innate/drug effects , Immunologic Factors , Influenza A virus , Influenza, Human/immunology , Interleukin-1beta/metabolism , Lung/drug effects , Pneumonia, Bacterial/immunology , Staphylococcal Infections/immunology , TYK2 Kinase/metabolism
3.
Histochem Cell Biol ; 147(6): 707-719, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28247028

ABSTRACT

Loss of alveolar barrier function with subsequent respiratory failure is a hallmark of severe pneumonia. Although junctions between endo- and epithelial cells regulate paracellular fluid flux, little is known about their composition and regulation in the human alveolar compartment. High autofluorescence of human lung tissue in particular complicates the determination of subcellular protein localization. By comparing conventional channel mode confocal imaging with spectral imaging and linear unmixing, we demonstrate that background fluorescent spectra and fluorophore signals could be rigorously separated resulting in complete recovery of the specific signal at a high signal-to-noise ratio. Using this technique and Western blotting, we show the expression patterns of tight junction proteins occludin, ZO-1 as well as claudin-3, -4, -5 and -18 and adherence junction protein VE-cadherin in naive or Streptococcus pneumoniae-infected human lung tissue. In uninfected tissues, occludin and ZO-1 formed band-like structures in alveolar epithelial cells type I (AEC I), alveolar epithelial cells type II (AEC II) and lung capillaries, whereas claudin-3, -4 and -18 were visualised in AEC II. Claudin-5 was detected in the endothelium only. Claudin-3, -5, -18 displayed continuous band-like structures, while claudin-4 showed a dot-like expression. Pneumococcal infection reduced alveolar occludin, ZO-1, claudin-5 and VE-cadherin but did not change the presence of claudin-3, -4 and -18. Spectral confocal microscopy allows for the subcellular structural analysis of proteins in highly autofluorescent human lung tissue. The thereby observed deterioration of lung alveolar junctional organisation gives a structural explanation for alveolar barrier disruption in severe pneumococcal pneumonia.


Subject(s)
Cadherins/metabolism , Persistent Fetal Circulation Syndrome/metabolism , Pneumococcal Infections/metabolism , Pulmonary Alveoli/abnormalities , Humans , Persistent Fetal Circulation Syndrome/microbiology , Pneumococcal Infections/microbiology , Pulmonary Alveoli/metabolism , Pulmonary Alveoli/microbiology , Streptococcus pneumoniae
4.
PLoS One ; 10(8): e0137108, 2015.
Article in English | MEDLINE | ID: mdl-26317436

ABSTRACT

Streptococcus pneumoniae is a major cause of pneumonia, sepsis and meningitis. The pore-forming toxin pneumolysin is a key virulence factor of S. pneumoniae, which can be sensed by the NLRP3 inflammasome. Among the over 90 serotypes, serotype 1 pneumococci (particularly MLST306) have emerged across the globe as a major cause of invasive disease. The cause for its particularity is, however, incompletely understood. We therefore examined pneumococcal infection in human cells and a human lung organ culture system mimicking infection of the lower respiratory tract. We demonstrate that different pneumococcal serotypes differentially activate inflammasome-dependent IL-1ß production in human lung tissue and cells. Whereas serotype 2, 3, 6B, 9N pneumococci expressing fully haemolytic pneumolysins activate NLRP3 inflammasome-dependent responses, serotype 1 and 8 strains expressing non-haemolytic toxins are poor activators of IL-1ß production. Accordingly, purified haemolytic pneumolysin but not serotype 1-associated non-haemolytic toxin activates strong IL-1ß production in human lungs. Our data suggest that the evasion of inflammasome-dependent innate immune responses by serotype 1 pneumococci might contribute to their ability to cause invasive diseases in humans.


Subject(s)
Inflammasomes/metabolism , Lung/metabolism , Lung/microbiology , Streptococcus pneumoniae/physiology , Bacterial Proteins/metabolism , Caspase 1/metabolism , Hemolysis , Humans , Interleukin-1beta/biosynthesis , Lung/cytology , Lung/immunology , Species Specificity , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/immunology , Streptococcus pneumoniae/metabolism , Streptolysins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...